Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability

Daniel Samarai; Nazim Isma; Sandra Lindstedt; Joanna Hlebowicz

doi:10.1016/j.thromres.2021.08.025

Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability

Daniel Samarai, Nazim Isma, Sandra Lindstedt, Joanna Hlebowicz

Skåne University Hospital

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	7-9
Antal sidor	3
Tidskrift	Thrombosis Research
Volym	207
DOI	https://doi.org/10.1016/j.thromres.2021.08.025
Status	Published - 2021

Ämnesklassifikation (UKÄ)

Kardiologi

Tillgång till dokument

10.1016/j.thromres.2021.08.025

1 Doktorsavhandling (sammanläggning)

Management of Adults with Congenital Heart Disease
Samarai, D., 2022, Lund: Lund University, Faculty of Medicine. 55 s.
Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Öppen tillgång
Fil

Citera det här

@article{8167ed9f601a4268b5679cb5042f150b,

title = "Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability",

keywords = "Adult congenital heart disease, Anticoagulant therapy, International normalized ratio, Oral vitamin K antagonists, Time in therapeutic range",

author = "Daniel Samarai and Nazim Isma and Sandra Lindstedt and Joanna Hlebowicz",

year = "2021",

doi = "10.1016/j.thromres.2021.08.025",

language = "English",

volume = "207",

pages = "7--9",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier",

}

TY - JOUR

T1 - Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease

T2 - TTR and INR variability

AU - Samarai, Daniel

AU - Isma, Nazim

AU - Lindstedt, Sandra

AU - Hlebowicz, Joanna

PY - 2021

Y1 - 2021

KW - Adult congenital heart disease

KW - Anticoagulant therapy

KW - International normalized ratio

KW - Oral vitamin K antagonists

KW - Time in therapeutic range

U2 - 10.1016/j.thromres.2021.08.025

DO - 10.1016/j.thromres.2021.08.025

M3 - Letter

C2 - 34482164

AN - SCOPUS:85114144997

SN - 0049-3848

VL - 207

SP - 7

EP - 9

JO - Thrombosis Research

JF - Thrombosis Research

ER -

Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability

Ämnesklassifikation (UKÄ)

Tillgång till dokument

Forskningsoutput

Management of Adults with Congenital Heart Disease

Citera det här